Ranibizumab and PRP in Patients With CSDME and Peripheral Nonperfusion (RaScaL)
This study has been completed.
Retina Associates of Florida, P.A.
Information provided by (Responsible Party):
Ivan J. Suner, MD, Retina Associates of Florida, P.A.
First received: December 26, 2008
Last updated: November 1, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2011|
|Primary Completion Date:||July 2011 (Final data collection date for primary outcome measure)|